ESMO 2019 | Temporal patterns among older patients with AML

Amer Zeidan

Amer Zeidan, MBBS, MHS, Yale Cancer Center, New Haven, CT, discusses temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukaemia (AML). This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video